0001472012-19-000004.txt : 20191119 0001472012-19-000004.hdr.sgml : 20191119 20191119154455 ACCESSION NUMBER: 0001472012-19-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191119 DATE AS OF CHANGE: 20191119 EFFECTIVENESS DATE: 20191119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immunome Inc. CENTRAL INDEX KEY: 0001472012 IRS NUMBER: 770694340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-353741 FILM NUMBER: 191231047 BUSINESS ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 610-321-3700 MAIL ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 D 1 primary_doc.xml X0708 D LIVE 0001472012 Immunome Inc. 665 STOCKTON DRIVE SUITE 300 EXTON PA PENNSYLVANIA 19341 610-321-3700 DELAWARE None None Corporation true Purnanand Sarma 665 Stockton Drive Suite 300 Exton PA PENNSYLVANIA 19341 Executive Officer Director Michael J. Morin 665 Stockton Drive Suite 300 Exton PA PENNSYLVANIA 19341 Executive Officer Director Michael D. Widlitz 665 Stockton Drive Suite 300 Exton PA PENNSYLVANIA 19341 Director Philip R. Wagenheim 665 Stockton Drive Suite 300 Exton PA PENNSYLVANIA 19341 Director John LaMattina 665 Stockton Drive Suite 300 Exton PA PENNSYLVANIA 19341 Director Michael Lefenfeld 665 Stockton Drive Suite 300 Exton PA PENNSYLVANIA 19341 Director I. Wistar Morris 665 Stockton Drive Suite 300 Exton PA PENNSYLVANIA 19341 Director Michael D. Rapoport 665 Stockton Drive Suite 300 Exton PA PENNSYLVANIA 19341 Director David Kutcher 665 Stockton Drive Suite 300 Exton PA PENNSYLVANIA 19341 Executive Officer Scott Dessain 665 Stockton Drive Suite 300 Exton PA PENNSYLVANIA 19341 Executive Officer Biotechnology Decline to Disclose 06b false 2019-11-04 false true true Shares of common stock issuable upon conversion of Series A preferred stock false 0 16800000 9300000 7500000 Inclusive of proceeds from conversion of Notes. Series A financing expansion - to occur in multiple closings false 35 0 0 500000 true false Immunome Inc. Purnanand Sarma Purnanand Sarma CEO 2019-11-19